Skip to main content

Latest Mass Tort News and Updates

J&J Sues US Govt Over Medicare Drug Price Negotiations

Categories: Drugs

Johnson & Johnson filed a lawsuit against the federal government, making it the latest producer of opioid drugs to try to stop a policy that allows the…

FDA Announces Warning Label Update Over Tepezza

Categories: Drugs

Federal regulators have announced a warning label update over Horizon Pharmaceuticals' Tepezza which may cause severe and permanent hearing damage.

Juul To Launch Vapes With Parental Locks

Categories: Drugs

A new line of vapes from Juul will have a unique smartphone app with age verification and parental controls.

Mallinckrodt In Talks To Avoid Opioid Settlements

Categories: Drugs

Mallinckrodt, a pharmaceutical company, is in talks with hedge funders about declaring bankruptcy and skipping payments meant to aid opioid addicts.

Cook County Logs Record 2,000 Opioid Deaths In 2022

Categories: Drugs

According to data revealed, opioid overdose deaths among Cook County residents continue to occur at an extraordinary pace, with fatalities reaching an all-…

Study: 1 In 5 Adults With Opioid Addiction Get Treatment

Categories: Drugs

Evidence-based treatments for substance use continued to be gravely underutilized as opioid overdose fatalities in the United States hit record highs, a…

Governor Of New York Announces $22M To Combat Opioid Crisis

Categories: Drugs

The governor of New York has announced more than $22 million in funding for a variety of opioid addiction prevention, treatment, harm reduction, and…

NY Launches Opioid Awareness Campaign

Categories: Drugs

After eight individuals overdosed there in the first week of July, authorities in the US state of New York started a campaign to raise awareness about the growing…

Opioid Company Looking To Avoid VA's $20M Settlement

Categories: Drugs

A scheme to avoid paying more than $1 billion as part of a federal settlement for victims of the opioid crisis is being floated by one of the big…

FDA Approves Second Nasal Spray To Combat Opioid Crisis

Categories: Drugs

RiVive, a 3 mg naloxone hydrochloride nasal spray, has been given the go-ahead by the U.S. Food and Drug Administration for over-the-counter (OTC), nonprescription use in the treatment…

ISO 27001
A+ rating
CAALA _1
CAOC
NYSTLA
gdpr-website (1)
NSIC-CRISIL (1) 1
Hipaa_0